Opentrons Flex NeoSwitch Workstation

Opentrons and its Neochromosome subsidiary have launched the Opentrons Flex neoSwitch Workstation powered by the Neochromosome neoSwitch platform for in-house antibody discovery. The workstation enables automation of the neoSwitch antibody discovery workflow including high-throughput purification of binders for rapid characterization, Opentrons said. The neoSwitch antibody discovery platform is designed to toggle between yeast surface display for binder selection and protein secretion for downstream evaluation of hits. This integration eliminates traditionally labor-intensive and time-consuming subcloning and protein-expression steps, significantly reducing overall process timelines, the company said. Users can access ready-to-use, high-diversity antibody libraries built by Neochromosome or Neochromosome's custom DNA library services.